Share

We're really excited that these genomics companies, says Ark's Simon Barnett

Simon Barnett, ARK Invest's genomics analyst, discusses the company's belief in Invitae, its other top picks and why ARK invests the way it does.
03:03
Mon, Apr 12 20216:28 PM EDT